Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
251,80 € ↑6,70 (2,73%)
2026-06-03
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership426,723 shares
Latest Disclosed Value $ 141,189,839
Squarepoint Ops LLC ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 426,723 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $121,914,761 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 350,969 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 21.58% during the quarter. The current value of the position is $107,448,851 USD.

Squarepoint Ops LLC has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 69,100 of underlying shares valued at $22,863,117 USD and put options representing 12,400 of underlying shares valued at $4,102,788 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 426,723 75,754 21.58 141,190 1.17 0.1659
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 350,969 205,404 141.11 139,563 110.26 0.1485
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 145,565 143,119 5,851.14 66,378 8,228.36 0.0667
2025-08-27 2025-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 2,446 -3,822 -60.98 798 -52.90 0.0008
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,446 -3,822 798 0.0008
2025-08-27 2025-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 6,268 -121,429 -95.09 1,692 -94.37 0.0021
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,268 -121,429 1,692 0.0021
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 127,697 84,996 199.05 30,048 155.86 0.0296
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 42,701 -56,093 -56.78 11,744 -51.08 0.0184
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 98,794 -481,647 -82.98 24,007 -72.33 0.0397
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 580,441 244,615 72.84 86,747 34.95 0.1493
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 335,826 98,192 41.32 64,280 52.74 0.1217
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 237,634 70,011 41.77 42,085 32.18 0.1040
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 167,623 34,395 25.82 31,838 19.30 0.0975
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 133,228 131,019 5,931.15 26,688 4,993.13 0.1088
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,209 -35,541 -94.15 525 -93.07 0.0021
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 37,750 -87,350 -69.82 7,556 -58.59 0.0381
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 125,100 87,662 234.15 18,246 198.48 0.1015
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 37,438 37,438 6,113 0.0262
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -23,308 -100.00 0 -100.00
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 23,308 -4,183 -15.22 3,029 -24.33 0.0226
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 27,491 24,359 777.75 4,003 762.72 0.0539
2020-08-14 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,132 -8,604 -73.31 464 -63.66 0.0075
2020-05-15 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,736 -66,557 -85.01 1,277 -85.84 0.0327
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 78,293 78,293 9,017 0.0536
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -21,792 -100.00 0 -100.00
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 21,792 9,472 76.88 1,581 37.36 0.0154
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 12,320 12,320 1,151 0.0122
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -74,930 -100.00 0 -100.00
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 74,930 -15,188 -16.85 6,558 -26.12 0.0785
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 90,118 61,372 213.50 8,876 159.23 0.1176
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 28,746 28,746 3,424 0.0544
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -26,530 -100.00 0 -100.00
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 26,530 15,730 145.65 2,116 281.95 0.0416
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 10,800 -700 -6.09 554 28.54 0.0153
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,500 4,500 64.29 431 -9.07 0.0176
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,000 7,000 0.00 474 0.0315
2016-08-15 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -8,000 -100.00 0 -100.00
2016-05-16 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,000 2,800 53.85 502 2.45 0.0389
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 5,200 5,200 490 0.0537
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 69,100 -5.47 22,863 -21.35 n/a n/a n/a
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 73,100 308.38 29,068 256.14 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 17,900 616.00 8,162 901.47 n/a n/a n/a
2025-08-27 2025-06-30 13F/A ALNYLAM PHARMACEUTICALS COM Call 2,500 19.05 815 43.74 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 2,500 815 n/a n/a n/a
2025-08-27 2025-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Call 2,100 -90.99 567 -89.66 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 2,100 567 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 23,300 187.65 5,483 146.16 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 8,100 2,228 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 20,000 2,989 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 13,200 1,864 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 12,400 235.14 4,103 178.86 n/a n/a n/a
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 3,700 -56.47 1,471 -62.05 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 8,500 97.67 3,876 176.46 n/a n/a n/a
2025-08-27 2025-06-30 13F/A ALNYLAM PHARMACEUTICALS COM Put 4,300 -10.42 1,402 8.18 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 4,300 1,402 n/a n/a n/a
2025-08-27 2025-03-31 13F/A ALNYLAM PHARMACEUTICALS COM Put 4,800 -73.77 1,296 -69.90 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 4,800 1,296 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 18,300 408.33 4,306 334.95 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 3,600 200.00 990 240.21 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 1,200 -94.00 292 -90.26 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 20,000 2,989 n/a n/a n/a
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 1,900 -97.06 322 -96.47 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 64,600 9,121 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.